B. Longenecker

D. Miles, M. Reddish, R. Rubens, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors.

M. Reddish, B. Longenecker, B. Agrawal, 1996, Journal of immunology.

Radioiodinated peanut lectin: Clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function

B. Longenecker, B. M. Longenecker, E. Abdi, 1986, European Journal of Nuclear Medicine.

Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.

M. Reddish, B. Longenecker, B. M. Longenecker, 1994, Advances in experimental medicine and biology.

Glycopeptide-and carbohydratebased synthetic vaccines for the immunotherapy of cancer

M. Reddish, B. Longenecker, R. Koganty, 1996 .

Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer

Sang-Nae Cho, B. Longenecker, D. Nahm, 1999, Journal of Cancer Research and Clinical Oncology.

Expression of genetic resistance to an oncogenic herpesvirus at the target cell level

B. Longenecker, W. Gallatin, 1979, Nature.

Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients.

M. Reddish, B. Longenecker, B. M. Longenecker, 1997, Journal of immunotherapy.

A strong, preferential response of mice to polymorphic antigenic determinants of the chicken MHC, analyzed with mouse hybridoma (monoclonal) antibodies

T. Mosmann, B. Longenecker, C. Shiozawa, 1979, Immunogenetics.

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

J. Taylor‐Papadimitriou, M. Reddish, E. Lalani, 2005, Cancer Immunology, Immunotherapy.

Immunogenicity and antitumor activity of a liposomal MUC1 peptide‐based vaccine

M. Reddish, B. Longenecker, G. Zimmermann, 1998, International journal of cancer.

Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells

M. Reddish, B. Longenecker, Philip S. Livingston, 1999, Cancer Immunology, Immunotherapy.

Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.

B. Longenecker, M. Krantz, B. Agrawal, 1998, Cancer research.

Tumor cell surface a'#,B integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-1 1 O/VCAM-1

D. Taichman, A. Aruffo, B. Longenecker, 2003 .

Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes.

M. Reddish, B. Longenecker, M. Krantz, 1998, International immunology.

Does pregnancy immunize against breast cancer?

M. Reddish, B. Longenecker, M. Krantz, 1995, Cancer research.

MUC1 mucin-mediated regulation of human T cells.

B. Longenecker, B. Agrawal, 2005, International immunology.

Active Specific Immunotherapy of a Murine Mammary Adenocarcinoma Using a Synthetic Tumor-associated Glycoconjugate1

M. Madej, B. Longenecker, B. M. Longenecker, 2006 .

Possible Utility of Serum Determinations of CA 125 and CA 27.29 in Breast Cancer Management

M. Suresh, B. Longenecker, D. Jette, 1991, The International journal of biological markers.

The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.

L. Pilarski, M. Reddish, J. Hugh, 1996, Cancer research.

Characterization and Selection Criteria of Monoclonal Antibodies for Tumor Imaging Studies

M. Suresh, B. Longenecker, B. M. Longenecker, 1988 .

Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody.

B. Longenecker, B. M. Longenecker, A. Noujaim, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Human tumor cell membrane glycoprotein associated with protein kinase activity

A. Shaw, B. Longenecker, J. Seehafer, 1984, International journal of cancer.

Biochemical characterization of human carcinoma surface antigen associated with protein kinase activity

B. Longenecker, J. Seehafer, B. M. Longenecker, 1984, International journal of cancer.

Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.

B. Sandmaier, M. Reddish, B. Longenecker, 1999, Journal of immunotherapy.

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.

M. Reddish, B. Longenecker, B. M. Longenecker, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary note.

K. Handa, S. Hakomori, B. Longenecker, 2001, Biochemical and biophysical research communications.

Restricted expression of an MHC alloantigen in cells of the erythroid series: a specific marker for erythroid differentiation.

T. Mosmann, B. Longenecker, 1980, Journal of supramolecular structure.

Murine T-cell clones specific for chicken erythrocyte alloantigens.

T. Mosmann, M. Giedlin, B. Longenecker, 1986, Cellular immunology.

Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.

B. Longenecker, K. Lloyd, S. Welt, 1996, Hybridoma.

Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

M. Reddish, B. Longenecker, S. Itzkowitz, 1995, Cancer research.

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

M. Reddish, B. Longenecker, J. Nabholtz, 2005, Cancer Immunology, Immunotherapy.

A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.

V. Miller, B. Longenecker, A. Greenberg, 1986, Journal of immunology.

Two novel monoclonal antibodies have potential for gynecologic cancer imaging

B. Longenecker, A. McEwan, L. Golberg, 1991 .

Active specific immunotherapy (ASI). An immunological approach to ovarian cancer treatment

B. Longenecker, G. Maclean, 1995 .

Major histocompatibility complex of chickens: Genes, antigens, differential features, and special contributions to our knowledge of the advantages of polymorphism of cell surface antigens

B. Longenecker, 1982, Survey of immunologic research.

Renal tubular receptor imaging with iodine-131-labeled peanut lectin: pharmacokinetics and renal clearance mechanism in animals.

M. Suresh, B. Longenecker, Y. Tam, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Further Evidence that the Human Differentiation Antigen p24 Possesses Activity Associated with Protein Kinase

B. Longenecker, G. Antoun, B. M. Longenecker, 1986 .

Lymphoma induced by herpesvirus: Resistance associated with a major histocompatibility gene

B. Longenecker, J. Gavora, J. Spencer, 1976, Immunogenetics.

Tumor Markers and Their Relevance in the Design of Radioimmunoimaging Experiments

M. Suresh, B. Longenecker, A. Noujaim, 1986 .

Alteration of apparent specificity of monoclonal (hybridoma) antibodies recognizing polymorphic histocompatibility and blood group determinants.

T. Mosmann, B. Longenecker, M. Gallatin, 1980, Journal of immunology.

A T-cell antigen system of chickens: Ly-4 and Marek's disease

B. Longenecker, D. Gilmour, F. Pazderka, 1977, Immunogenetics.

Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable Virus.

B. Longenecker, L. Lee, R. Witter, 1976, Journal of the National Cancer Institute.

In ovo assay for Marek's disease virus and turkey herpesvirus

B. Longenecker, J. Gavora, B. M. Longenecker, 1975, Infection and immunity.

Role of the major histocompatibility complex in resistance to Marek's disease: restriction of the growth of JMV-MD tumor cells in genetically resistant birds.

B. Longenecker, J. Gavora, J. Spencer, 1977, Advances in experimental medicine and biology.

A new class of infectious agents detectable by the production of chorioallantoic membrane lesions by human lymphoblastoid cell lines and their culture supernatants.

B. Longenecker, E. Sanders, J. Menezes, 1977, Journal of the National Cancer Institute.

Organ specific metastasis with special reference to avian systems

M. Kieran, B. Longenecker, B. M. Longenecker, 2004, Cancer and Metastasis Reviews.

Structure and properties of the major histocompatibility complex of the chicken. Speculations on the advantages and evolution of polymorphism

T. Mosmann, B. Longenecker, B. M. Longenecker, 2004, Immunogenetics.

Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).

B. Longenecker, B. M. Longenecker, P. Y. Fung, 1991, Cancer research.

Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.

M. Reddish, B. Longenecker, M. Krantz, 1998, Bioconjugate chemistry.

Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy

S. Poppema, M. Reddish, A. Berg, 1996, Cancer Immunology, Immunotherapy.

The major histocompatibility complex of the chicken

B. Longenecker, B. M. Longenecker, F. Pazderka, 1975, Immunogenetics.

Clonal variation and functional correlation of organ‐specific metastasis and an organ‐specific metastasis‐associated antigen

B. Longenecker, P. Shearman, 1981, International journal of cancer.

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

J. Taylor‐Papadimitriou, D. Miles, M. Reddish, 1996, British Journal of Cancer.

In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model

M. Suresh, B. Longenecker, B. M. Longenecker, 2004, European Journal of Nuclear Medicine.

Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA

M. Suresh, B. Longenecker, B. M. Longenecker, 1985, International journal of cancer.

Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate.

M. Madej, B. Longenecker, R. Koganty, 1990, Cancer research.

Analysis of human tumor associated Thomsen-Friedenreich antigen.

M. Suresh, B. Longenecker, B. M. Longenecker, 1990, Cancer research.

MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.

J. Hugh, B. Longenecker, M. Krantz, 1998, Cancer research.

A monoclonal antibody specific for the Thomsen-Friedenreich cryptic T antigen.

B. Longenecker, A. F. Rahman, 1982, Journal of immunology.

Antibody-mediated cellular cytotoxicity against Raji cells ADCC(RAJI): Evaluation of false positives in the detection of circulating immune complexes by Raji-cell assay

B. Longenecker, M. Dasgupta, B. M. Longenecker, 1982, Journal of Clinical Immunology.

Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells.

B. Longenecker, P. Simmons, B. Torok-Storb, 1992, Blood.

Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties.

B. Longenecker, M. Krantz, R. Koganty, 2002, Bioorganic & medicinal chemistry letters.

The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy.

B. Longenecker, S. Gendler, B M Longenecker, 1998, Molecular medicine today.

A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.

B. Longenecker, G. Lauzon, T. Zipf, 1983, Journal of immunology.

“Natural” Antibodies to chicken MHC antigens are present in mice, rats, humans, alligators and allogeneic chickens

T. Mosmann, B. Longenecker, 2005, Immunogenetics.

In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors.

M. Reddish, B. Longenecker, B. Agrawal, 1996, Journal of immunology.

Detection of a cell-surface antigen correlated with organ-specific metastasis

B. Longenecker, B. M. Longenecker, P. Shearman, 1980, Nature.

Histocompatibility of chicken populations selected for resistance to Marek's disease

B. Longenecker, H. A. Stone, F. Pazderka, 1975, Immunogenetics.

A monoclonal antibody against chicken MHC class I (B-F) antigens

M. Kieran, B. Longenecker, J. Pink, 2004, Immunogenetics.

Comparison of the 40 kDa hematopoietic cell antigens bound by monoclonal antibodies IV.3, 41H.16 and KB61.

B. Longenecker, G. Antoun, B. M. Longenecker, 1989, Molecular immunology.

Anti‐MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

M. Reddish, B. Longenecker, B. M. Longenecker, 1998, International journal of cancer.

Mucin 1-Specific Immunotherapy in a Mouse Model of Spontaneous Breast Cancer

B. Longenecker, C. Madsen, S. Gendler, 2003, Journal of immunotherapy.

Nomenclature for chicken major histocompatibility (B) complex

D. L. Ewert, N. Bumstead, J. Gogusev, 2004, Immunogenetics.

Homing Receptors as Functional Markers for Classification, Prognosis, and Therapy of Leukemias and Lymphomas

M. Kieran, B. Longenecker, B. Kamenov, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The graft-versus-host reaction to minor alloantigens.

B. Longenecker, B. M. Longenecker, F. Pazderka, 1973, Cellular immunology.

The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.

M. Reddish, B. Longenecker, B. Agrawal, 1998, Cancer research.

Correlation of erythrocytic peripheral blood chimaerism and putative bone marrow precursors bearing erythroid differentiation (B-G) antigens using monoclonal antibodies immobilized on fluorescent latex spheres.

M. Kieran, B. Longenecker, 1984, JIM - Journal of Immunological Methods.

Tolerance and autoimmunity to erythroid differentiation (B-G) major histocompatibility complex alloantigens of the chicken

B. Longenecker, C. Havele, T. Wegmann, 1982, The Journal of experimental medicine.

Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.

B. Longenecker, M. Krantz, A. Campbell, 2002, Biochemistry.

Clinical Evaluation of a New Two-Site Assay for CA125 Antigen

M. Suresh, B. Longenecker, V. Capstick, 1991, The International journal of biological markers.